Cargando…
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
B-cell maturation antigen is expressed on plasma cells. In this study, we have identified serum B-cell maturation antigen as a novel biomarker that can monitor and predict outcomes for multiple myeloma patients. Compared to healthy donors, patients with multiple myeloma showed elevated serum B-cell...
Autores principales: | Ghermezi, Michael, Li, Mingjie, Vardanyan, Suzie, Harutyunyan, Nika Manik, Gottlieb, Jillian, Berenson, Ariana, Spektor, Tanya M., Andreu-Vieyra, Claudia, Petraki, Sophia, Sanchez, Eric, Udd, Kyle, Wang, Cathy S., Swift, Regina A., Chen, Haiming, Berenson, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395119/ https://www.ncbi.nlm.nih.gov/pubmed/28034989 http://dx.doi.org/10.3324/haematol.2016.150896 |
Ejemplares similares
-
Removal of a Silicone Gel Breast Implant in a Multiple Myeloma Patient Improved Disease Status: A Case Report
por: Henning, Chace, et al.
Publicado: (2020) -
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
por: Stampfer, Samuel D., et al.
Publicado: (2021) -
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients
por: Visram, A., et al.
Publicado: (2021) -
Loss of anti‐spike antibodies following mRNA vaccination for COVID‐19 among patients with multiple myeloma
por: Stampfer, Samuel D., et al.
Publicado: (2023) -
Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients
por: Stampfer, Samuel D., et al.
Publicado: (2021)